Neuroradiology

Less than Half of American Adults Would Dial 911 for Stroke, Reveals New Survive Stroke Week Survey

Retrieved on: 
Lundi, mai 6, 2024
Education, The Harris Poll, Society, Neuroradiology, Probability, Medical imaging, Social media, Safety, Emergency, Policy, Professor, Death, Brown University, Rhode Island Hospital, Employment, Friends, White, Patient, Medicine, Multimedia, Marital status, Get Ahead, Diagnosis, PSAS, Thrombectomy, Organization, Disability, Ageing, Dietary supplement

FAIRFAX, Va., May 6, 2024 /PRNewswire/ -- Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common symptom of stroke—statistics that emphasize the need for more education, particularly during Survive Stroke Week (May 6-12).

Key Points: 
  • The longer a patient's treatment is delayed, the greater the impact of a stroke, including the potential of severe disability and death.
  • Black adults are less likely to call 911 (33%) if they are experiencing a common stroke symptom than White (44%) and Hispanic (47%) adults.
  • More than one-fifth (22%) of adults say they wouldn't call 911 because they would be embarrassed to overreact.
  • Get Ahead of Stroke is a national public education and advocacy campaign designed to improve systems of care for stroke patients.

Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use

Retrieved on: 
Mardi, janvier 9, 2024
Technology, Medical Devices, Neurology, Health Technology, Software, Biotechnology, Radiology, Health, Artificial Intelligence, DWI, Hospital, Neuroradiology, Multimedia, Hyperfine structure, Food and Drug Administration, UKCA, AI, Workflow, Food, Acquisition, FDA, CE, Medical imaging

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced the launch of the AI-powered eighth generation of Swoop® system software.

Key Points: 
  • Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced the launch of the AI-powered eighth generation of Swoop® system software.
  • The latest software improves Swoop® system image quality and introduces valuable ease-of-use features, including a real-time aid for more precise patient loading and positioning and a streamlined image upload process.
  • Hyperfine, Inc. will roll out software updates for the Swoop® system to users in the coming weeks.
  • For more information about the Swoop® Portable MR Imaging® system, please visit hyperfine.io .

Leading Neurointerventionalists Say New Insights on TRIAGE-STROKE and RACECAT Affirm Benefits of Direct Transport to CSCs for ELVO Patients

Retrieved on: 
Mardi, décembre 19, 2023
CSCS, TCC, Neuroradiology, State, PSC, Risk, Ambient occlusion, Research, EMS, National Association, Health, MD, Triage, ELVO, Stroke, Column, Standard of care, Society, Death, Transport, Patient, Journal, CSC, Life, Pharmaceutical industry

FAIRFAX, Va., Dec. 19, 2023 /PRNewswire/ -- In an Editor's Column published in the Journal of NeuroInterventional Surgery (JNIS), leaders of the Society of NeuroInterventional Surgery (SNIS) conclude that the entire body of research, including evidence from two new prospective trials, clearly confirm that most patients with emergent large vessel occlusions (ELVO) will benefit from triage directly to comprehensive stroke centers (CSCs).

Key Points: 
  • Since the release of this prospective data earlier this year, SNIS leaders say trade media and select hospital systems have issued messaging proclaiming, without qualification, that direct triage programs are ineffective.
  • This has caused concerns about risks to patient care and outcomes in the neurointerventional community.
  • Globally, mechanical thrombectomy is not only considered effective for eligible patients, but firmly established as the standard of care for ELVO patients.
  • These are life and death decisions, and it is our duty as care providers to prioritize patient outcomes over additional profits."

Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.

Retrieved on: 
Mardi, novembre 14, 2023
Research, Safety, SAN, NIHSS, Route, Patient, Medicine, Thrombectomy, Cooper University Hospital, Embolus, Neuroradiology, Doctor of Philosophy, Medical device, Nursing, Stroke, MD

SAN MATEO, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced compelling results from a multicenter clinical study 1 on the Tenzing® 7 Delivery Catheter published in Stroke: Vascular and Interventional Neurology.

Key Points: 
  • SAN MATEO, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced compelling results from a multicenter clinical study 1 on the Tenzing® 7 Delivery Catheter published in Stroke: Vascular and Interventional Neurology.
  • "Early clinical and in vitro experiences have always shown the potential of the Tenzing 7 delivery catheter.
  • "These findings underline our unwavering commitment to elevating patient outcomes through the development of best-in-class neurovascular intervention tools,” said Joey D. English, MD, PhD, Chief Medical Officer at Route 92 Medical.
  • Tenzing is a major advance.”
    For more information about Route 92 Medical and the Tenzing 7 Delivery Catheter, visit www.route92medical.com .

Kandu Health Announces Clinical Evidence Demonstrating the Benefits of its Remote Post-Acute Care Offerings for Stroke Recovery

Retrieved on: 
Mercredi, décembre 6, 2023
General Health, Other Health, Hospitals, Health, Managed Care, Assistant, Conference, Navigator, Patient, Digital platform, Social determinants of health, Standard of care, Kandu, Partnership, Neuroradiology, Survivor, Society, Poster, MRS, Nursing, Stroke, MD

Kandu™ Health , a tech-enabled healthcare services company that is changing the course of stroke recovery and post-acute care, today announced new data shared at two conferences: the Society of Vascular and Interventional Neurology (SVIN) Annual Meeting in Miami Beach and the Association of Neurovascular Clinicians (ANVC) Annual Conference in Las Vegas.

Key Points: 
  • Kandu™ Health , a tech-enabled healthcare services company that is changing the course of stroke recovery and post-acute care, today announced new data shared at two conferences: the Society of Vascular and Interventional Neurology (SVIN) Annual Meeting in Miami Beach and the Association of Neurovascular Clinicians (ANVC) Annual Conference in Las Vegas.
  • At SVIN, Dr. Nancey Tsai, Medical Director for Kandu Medical Services and Assistant Professor at MUSC College of Medicine, presented a poster titled “Preliminary Outcomes of a Survivor-Centric Digital Platform in Stroke Recovery.” The poster shared results from the first 60 graduates of Kandu’s remote post-acute service.
  • In this analysis, Kandu program graduates experienced all-cause inpatient readmission rates of 4% at 30 days and 10% at 90 days; less than half of historically published unplanned readmission rates in similar populations.
  • “We look forward to continued partnership with our stakeholders to generate additional clinical evidence that demonstrates our value and informs policy and standard of care for stroke survivors.”

RapidAI Announces a Series of Industry Firsts – Unique Rapid Edge Cloud Platform, Breakthrough AI Non-Contrast CT Suite, International Expansion in Japan

Retrieved on: 
Lundi, novembre 27, 2023
Data Management, Health, Technology, Health Technology, Software, Artificial Intelligence, Cloud, Perfusion, Stroke, Privacy, Artificial intelligence, Patient, Algorithm, Neuroradiology, Computation, Trauma, Hospital, AI, Medical device, Video game, Medical imaging

Achieving Class III Shonin clearance in Japan – the second largest stroke market in the world – as the only advanced stroke imaging platform for support of mechanical thrombectomy determination.

Key Points: 
  • Achieving Class III Shonin clearance in Japan – the second largest stroke market in the world – as the only advanced stroke imaging platform for support of mechanical thrombectomy determination.
  • With the only MR-based perfusion platform available, Rapid is uniquely situated to help Japanese clinicians address their advanced imaging needs.
  • Record-breaking number of published papers – over 120 in 2023 alone – featuring Rapid technology and further demonstrating the superior clinical validation of the platform.
  • “While RapidAI pioneered the use of perfusion imaging in stroke, they are now pioneering the use of non-contrast CT imaging.

Samsung Ushers in a New Era of Diagnostic Solutions at RSNA 2023

Retrieved on: 
Mardi, novembre 21, 2023
Biotechnology, Technology, Other Health, Health, General Health, Radiology, Health Technology, Other Technology, Medical Devices, Mobile, Wireless, Hardware, Photon, X-ray, RSNA, Neck, Associate, Next Generation, Research, Annual general meeting, Steven Novella, Head, University, ICU, Level 4, PCD, Patient, Multimedia, Samsung Electronics, McCormick Place, Neuroradiology, FDA, Stroke, Booth, US FDA, MD, Harvard Medical School, Trauma, VMI, Massachusetts General Hospital, Doctor of Philosophy, CST, Samsung, Hospital, MCT, Medical imaging, Medical device

View the full release here: https://www.businesswire.com/news/home/20231121501923/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231121501923/en/
    The high-tech, yet highly mobile OmniTom Elite with Photon Counting Detector (PCD) CT scanner is designed to offer advanced imaging at the point-of-care.
  • In the near term, all current OmniTom users will have the opportunity to upgrade their scanners with the PCD technology.
  • Meanwhile, a limited number of premier research partners will aid in developing the full potential of OmniTom Elite with PCD.
  • OmniTom Elite with PCD is only supported for adult axial imaging for head and neck.

Rapid Medical's TIGERTRIEVER™ Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD

Retrieved on: 
Jeudi, novembre 16, 2023
Biotechnology, Hardware, General Health, Health, Medical Devices, Technology, Other Technology, Other Health, Journal of NeuroInterventional Surgery, Embolism, Artery, Annual general meeting, Sich, Plaque, ICAD, Reperfusion, Neuroradiology, Patient, University, Journal, Stroke, Intervention, Groin, Society for Vascular Medicine, MRS, Medical imaging

Rapid Medical™, a leading developer of advanced neurovascular devices, announces new data demonstrating excellent first-pass treatment success with the TIGERTRIEVER™ device in complex ischemic stroke patients with underlying intracranial atherosclerotic disease (ICAD).

Key Points: 
  • Rapid Medical™, a leading developer of advanced neurovascular devices, announces new data demonstrating excellent first-pass treatment success with the TIGERTRIEVER™ device in complex ischemic stroke patients with underlying intracranial atherosclerotic disease (ICAD).
  • “Patients with ICAD experiencing a stroke are very challenging to treat and often need rescue therapy such as stenting,” states Dr. Edgar Samaniego , Endovascular Neurologist at the University of Iowa and lead author.
  • “We achieved very high treatment success and lasting results with TIGERTRIEVER alone that we haven’t seen with other devices.
  • Moreover, TIGERTRIEVER in ICAD rivals the results only thought possible in non-ICAD patients.

Society of NeuroInterventional Surgery Congratulates President Mahesh Jayaraman, MD, FACR, on Appointment as Chair of Department of Diagnostic Imaging at Brown's Warren Alpert Medical School

Retrieved on: 
Mercredi, décembre 13, 2023
Health, Neck, Brain, Research, Policy, EMS, Head, Spine, Book, Get Ahead, Neuroradiology, Patient, Medical imaging, Stroke, Rhode Island Hospital, MD, Neurology, Cerebrovascular disease, Society, Neurosurgery, Alpert Medical School, Diagnosis, Education, Medical device

FAIRFAX, Va., Dec. 13, 2023 /PRNewswire/ -- The Society of NeuroInterventional Surgery (SNIS) congratulates SNIS President Mahesh Jayaraman, MD, FACR, on his promotion to Chair of the Department of Diagnostic Imaging at The Warren Alpert Medical School of Brown University and Chief of Diagnostic Imaging at Lifespan, effective January 1, 2024.

Key Points: 
  • FAIRFAX, Va., Dec. 13, 2023 /PRNewswire/ -- The Society of NeuroInterventional Surgery (SNIS) congratulates SNIS President Mahesh Jayaraman, MD, FACR, on his promotion to Chair of the Department of Diagnostic Imaging at The Warren Alpert Medical School of Brown University and Chief of Diagnostic Imaging at Lifespan, effective January 1, 2024.
  • He will also be appointed the Charles and Elfriede Collis-Frances Weeden Gibson Professor of Diagnostic Imaging.
  • "We are very grateful for his hard work, contributions, and commitment to his patients, and wish him success in his new roles."
  • He also serves as a Professor of Diagnostic Imaging, Neurology, and Neurosurgery at The Warren Alpert Medical School and the Director of the Neurovascular Center at Rhode Island Hospital.

AI May Aid in Diagnosing Adolescents with ADHD

Retrieved on: 
Mercredi, novembre 29, 2023
Health, RSNA, Champaign–Urbana metropolitan area, Brain, Research, DWI, Clutch (eggs), Data, Patient, Multimedia, ADHD, White matter, Neuroradiology, Artificial intelligence, FA, University, Newsroom, ABCD, Diagnosis, Deep learning, MRI, Biomarker, AI, Quality of life, Society, Radiology, Radiation, Education, Medical imaging, Dietary supplement

CHICAGO, Nov. 29, 2023 /PRNewswire/ -- Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and without attention-deficit/hyperactivity disorder (ADHD), researchers found significant differences in nine brain white matter tracts in individuals with ADHD.

Key Points: 
  • CHICAGO, Nov. 29, 2023 /PRNewswire/ -- Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and without attention-deficit/hyperactivity disorder (ADHD), researchers found significant differences in nine brain white matter tracts in individuals with ADHD.
  • In the U.S., an estimated 5.7 million children and adolescents between the ages of 6 and 17 have been diagnosed with ADHD.
  • The research team selected a group of 1,704 individuals from the ABCD dataset, including adolescents with and without ADHD.
  • With the help of AI, the researchers discovered that in patients with ADHD, FA values were significantly elevated in nine white matter tracts.